Dr.ย Ullasย Batra
MBBS, MD, DM Medical Oncology & Haematology, ECMO, FAGE
Co-Director โ Medical Oncology & Chief of Thoracic Medical Oncology
corporate_fareRajiv Gandhi Cancer Institute & Research Centre, Delhi
Ullas Batra
MBBS, MD, DM Medical Oncology & Haematology, ECMO, FAGE
Dr. Ullas Batra is Co-Director of Medical Oncology and Chief of Thoracic Medical Oncology at Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), Delhi. He specialises in lung cancer, thoracic malignancies, and systemic treatment of solid tumours, with a strong focus on biomarker-guided and precision oncology approaches.
With over 16 years of oncology experience at RGCIRC, Dr. Batra has built one of India's foremost thoracic oncology programmes. His clinical practice integrates molecular testing, next-generation sequencing, immunotherapy, and targeted therapy for patients with non-small cell lung cancer and other solid tumours. He has completed advanced training at MD Anderson Cancer Center (USA), Royal Adelaide Hospital (Australia), and ESMO and National University of Health preceptorships in Singapore. Dr. Batra has authored 49+ peer-reviewed publications and holds an American Society of Clinical Oncology International Innovation Grant (2021) for work integrating artificial intelligence in NSCLC. He is Convener of the Delhi Thoracic Oncology Group and has served as faculty at national and international oncology conferences.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Batra at RGCIRC, Delhi.
Why Consider Dr. Ullas Batra?
Dr. Batra combines deep clinical expertise in thoracic oncology with an active research programme in lung cancer biomarkers and precision medicine, making him a sought-after specialist for complex NSCLC and solid-tumour cases in India.
Areas of Specialisation
Thoracic oncology, precision medicine, and systemic cancer treatment
Dr. Batra's practice centres on evidence-based, biomarker-driven management of lung cancer and related thoracic malignancies, alongside systemic treatment of breast, gastrointestinal, and haematological cancers.
Thoracic & Lung Cancer Oncology
Comprehensive management of non-small cell and small cell lung cancers using molecular profiling and contemporary systemic therapies.
- arrow_rightEGFR mutation testing and EGFR-targeted therapy (osimertinib and related agents)
- arrow_rightALK and ROS1 fusion detection and targeted inhibitor therapy
- arrow_rightKRAS G12C and other driver mutation management
- arrow_rightMET exon 14 skipping, HER2, RET, and NTRK alterations
- arrow_rightComprehensive NGS panel interpretation for treatment planning
- arrow_rightLiquid biopsy and circulating tumour DNA monitoring
- arrow_rightBench-to-bedside biomarker application as reviewed in peer-reviewed publications
Immunotherapy & Targeted Therapy
Advanced systemic approaches for selected thoracic and solid tumour patients.
- arrow_rightPD-1 and PD-L1 inhibitor selection based on biomarker profile
- arrow_rightSingle-agent and combination immunotherapy regimens
- arrow_rightImmune-related adverse event recognition and management
- arrow_rightMolecularly matched oral and intravenous targeted agents
- arrow_rightResistance mechanism analysis and sequential therapy planning
Breast, GI & Haematological Cancers
Systemic oncology care for breast, gastrointestinal, and haematological malignancies.
- arrow_rightHormone receptor-positive, HER2-positive, and triple-negative breast cancer
- arrow_rightNeoadjuvant, adjuvant, and metastatic treatment planning
- arrow_rightSystemic therapy for gastric, colorectal, and other GI cancers
- arrow_rightChemotherapy and targeted agents for haematological malignancies
Procedures & Treatment Approaches
Systemic oncology services at RGCIRC, Delhi
Dr. Batra provides comprehensive systemic cancer treatment and multidisciplinary oncology care, with particular expertise in lung cancer treatment protocols informed by molecular profiling.
Systemic Cancer Treatment
Medical OncologyChemotherapy, immunotherapy, and combination regimens for lung, breast, GI, and haematological cancers.
Targeted Therapy Planning
Targeted TherapyMolecularly guided targeted treatment selection based on comprehensive biomarker profiling.
Diagnosis & Staging
DiagnosisWorkup, molecular diagnostics, and staging for thoracic and other malignancies.
Treatment Monitoring & Response Assessment
MonitoringOngoing disease monitoring, response evaluation, and management of treatment-related side effects.
Second Opinion Consultations
Second OpinionExpert review of pathology, imaging, and treatment plans for lung and solid tumour cases.
Research & Publications
Peer-reviewed contributions in lung cancer, biomarkers, and precision oncology
Dr. Batra has an active research profile with 49+ publications indexed across PubMed and peer-reviewed oncology journals. His research focuses on lung cancer biomarkers, NGS-guided treatment, targeted therapy outcomes, and real-world oncology in the Indian setting.
Dr. Batra's full publication list and current trial participation details are available on request. CancerFax can help coordinate academic consultation for eligible patients.
Education & Training
Dr. Batra completed his medical training in India, culminating in a DM in Medical Oncology and Haematology from Kidwai Memorial Institute of Oncology. He subsequently undertook international preceptorships at leading cancer centres in the USA, Australia, and Singapore.
Clinical Experience
Dr. Batra has spent his entire oncology career at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, progressing from Consultant III to Co-Director of Medical Oncology over 16+ years. He has led RGCIRC's Thoracic Medical Oncology programme since 2014.
Languages & International
Dr. Batra consults in the following languages. CancerFax can arrange professional medical interpreter support for patients who require assistance in other languages.
CancerFax can coordinate professional medical interpreter support for international patients seeking consultation with Dr. Batra.
CancerFax can coordinate professional medical interpreter support when required.
How CancerFax Helps You Access Dr. Ullas Batra
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Ullas Batra's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Ullas Batra's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Ullas Batra before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Ullas Batra's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Ullas Batra's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Ullas Batra's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Ullas Batra
Dr. Ullas Batra specialises in medical oncology with a primary focus on thoracic medical oncology, particularly lung cancer. His expertise covers EGFR-, ALK-, ROS1-, KRAS-, and other molecularly defined non-small cell lung cancers, as well as breast cancer, gastrointestinal malignancies, and haematological cancers.
Dr. Batra is based at Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) in Delhi, India, one of India's leading dedicated cancer hospitals with facilities at Rohini and Niti Bagh.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Batra, subject to hospital availability and case acceptance. Please submit your reports through the CancerFax platform and our team will handle the coordination with RGCIRC.
Submit your medical reports โ including pathology, imaging, molecular/NGS reports, and treatment history โ through CancerFax. The CancerFax team will review the documents, prepare the case summary, and coordinate the next steps with RGCIRC, subject to availability.
Yes. Dr. Batra's clinical practice includes immunotherapy (PD-1/PD-L1 checkpoint inhibitors) and a broad range of targeted agents for EGFR, ALK, ROS1, KRAS, MET, HER2, RET, and NTRK-altered non-small cell lung cancer. Treatment selection is guided by comprehensive molecular profiling and next-generation sequencing.
Yes. Dr. Batra has participated as principal investigator and co-investigator in Phase II and Phase III oncology clinical trials. He has 49+ peer-reviewed publications and was awarded the ASCO International Innovation Grant 2021 for work on artificial intelligence in NSCLC management. Eligibility for specific trials should be discussed directly with the RGCIRC team.
Connect with Ullas Batra Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.